ロード中...
Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer
The PI3K/Akt/mTOR (phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin) pathway regulates several key cellular functions and its dysregulation creates an environment that promotes tumorigenesis as well as resistance to therapy. The mTOR inhibitor everolimus has emerged as a...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3929343/ https://ncbi.nlm.nih.gov/pubmed/24648755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S30131 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|